Anant Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2005 in Ambernath East, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100MH2005PTC151401. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.19 M.
It upholds a compliant status. Employing 40 professional, Its leadership includes Anupama Ajit Godbole (Director), Ajit Anil Godbole (Managing Director), Anil Shankar Godbole (Director). Past directors included Madhavi Anil Godbole, Ajit Anil Godbole, Anil Shankar Godbole. It holds ₹5.74 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. W / 57 A, Additional Midc, Anand Nagar, Ambernath East, Maharashtra, 421507.
U24100MH2005PTC151401
151401
18 February 2005
₹1.80 M
₹1.19 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Anant Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Ajit Godbole | Director | 18 Feb 2005 | Current |
| Ajit Anil Godbole | Managing Director | 10 Feb 2010 | Current |
| Anil Shankar Godbole | Director | 18 Feb 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 May 2024 | Past |
| Pramod Abcsdd | Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Managing Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anant Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.19% decrease. The company also saw a substantial fall in profitability, with a 250.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Anant Pharmaceuticals had a public holding of 32.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹57,400,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹2.50 M | Open |
| 16 Aug 2024 | Others | ₹5.90 M | Open |
| 01 Jan 2024 | Others | ₹2.50 M | Open |
| 14 Mar 2023 | Others | ₹2.50 M | Open |
| 31 Dec 2022 | Others | ₹3.00 M | Open |
Explore comprehensive loan charge details -
Anant Pharmaceuticals has a workforce of 40 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Anant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anant Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 101141716 was registered on 30 Jul 2025. was completed.
The activity Anant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 5.90 M with Charge ID 100962099 was registered on 16 Aug 2024. was recorded as a recent event.
Progress on Anant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100850260 was registered on 01 Jan 2024. was documented.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100691972 was registered on 14 Mar 2023. was documented.
The CIN of Anant Pharmaceuticals Private Limited is U24100MH2005PTC151401.
Anant Pharmaceuticals Private Limited is headquartered at Plot No. W / 57 A, Additional Midc, Anand Nagar, Ambernath East, Maharashtra, 421507.
Anant Pharmaceuticals Private Limited was incorporated on 18 February 2005.
The current directors of Anant Pharmaceuticals Private Limited are
The primary industry of Anant Pharmaceuticals Private Limited is Manufacturing.
Anant Pharmaceuticals Private Limited is unlisted.
The authorized capital of Anant Pharmaceuticals Private Limited is ₹1.80 M, and the paid-up capital is ₹1.19 M.
The compliance status of Anant Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX